185 related articles for article (PubMed ID: 37560806)
1. Oral gonadotrophin-releasing hormone (GnRH) antagonists: the continuing search for the ideal nonsurgical therapy of uterine fibroids with a cautionary tale.
Sim-Ifere O; Aref-Adib M; Odejinmi F
Curr Opin Obstet Gynecol; 2023 Oct; 35(5):460-465. PubMed ID: 37560806
[TBL] [Abstract][Full Text] [Related]
2. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
3. [Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology].
Brazert M; Korman MP; Pawelczyk LA
Ginekol Pol; 2013 Sep; 84(9):794-800. PubMed ID: 24191519
[TBL] [Abstract][Full Text] [Related]
4. GnRH agonists and antagonists in therapy of symptomatic uterine fibroids - current roles and future perspectives.
Ciebiera M; Madueke-Laveaux OS; Feduniw S; Ulin M; Spaczyński R; Zgliczyńska M; Bączkowska M; Zarychta E; Łoziński T; Ali M; Al-Hendy A
Expert Opin Pharmacother; 2023; 24(16):1799-1809. PubMed ID: 37602464
[TBL] [Abstract][Full Text] [Related]
5. Medical management of fibroids.
Sankaran S; Manyonda IT
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Oral GnRh Antagonists in Patients With Uterine Fibroids: A Systematic Review.
Niaz R; Saeed M; Khan H; Ali MA; Irshad A; Faiz M; Irshad A; Fatima F; Tunio SA; Aiman W
J Obstet Gynaecol Can; 2022 Dec; 44(12):1279-1288. PubMed ID: 36368594
[TBL] [Abstract][Full Text] [Related]
8. Highlights on Medical Treatment of Uterine Fibroids.
Angioni S; D'Alterio MN; Daniilidis A
Curr Pharm Des; 2021; 27(36):3821-3832. PubMed ID: 33388011
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
10. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids.
Talaulikar VS; Manyonda IT
Adv Ther; 2012 Aug; 29(8):655-63. PubMed ID: 22903240
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
Cheng YM; Chou CY; Huang SC; Lin HC
BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
[TBL] [Abstract][Full Text] [Related]
12. Considerations on implementation of the newest treatment for symptomatic uterine fibroids: Oral GnRH antagonists.
de Lange ME; Semmler A; Clark TJ; Mol BWJ; Bet PM; Huirne JAF; Hehenkamp WJK
Br J Clin Pharmacol; 2024 Feb; 90(2):392-405. PubMed ID: 37653680
[TBL] [Abstract][Full Text] [Related]
13. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
Szamatowicz M; Kotarski J
Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
[TBL] [Abstract][Full Text] [Related]
14. Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.
Ali M; Raslan M; Ciebiera M; Zaręba K; Al-Hendy A
Expert Opin Drug Saf; 2022 Apr; 21(4):477-486. PubMed ID: 34612122
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review.
Donnez J; Dolmans MM
Reprod Biomed Online; 2020 Sep; 41(3):431-442. PubMed ID: 32703756
[TBL] [Abstract][Full Text] [Related]
16. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
Adamson GD
Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
[TBL] [Abstract][Full Text] [Related]
17. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
Zeng C; Gu M; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Lethaby AE; Vollenhoven BJ
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
[TBL] [Abstract][Full Text] [Related]
19. Uterine leiomyoma: available medical treatments and new possible therapeutic options.
Islam MS; Protic O; Giannubilo SR; Toti P; Tranquilli AL; Petraglia F; Castellucci M; Ciarmela P
J Clin Endocrinol Metab; 2013 Mar; 98(3):921-34. PubMed ID: 23393173
[TBL] [Abstract][Full Text] [Related]
20. Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects.
Telek SB; Gurbuz Z; Kalafat E; Ata B
J Minim Invasive Gynecol; 2022 May; 29(5):613-625. PubMed ID: 34942350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
